157 related articles for article (PubMed ID: 1952863)
1. Pharmacokinetics and adverse effects of 20-mg/kg/day trimethoprim and 100-mg/kg/day sulfamethoxazole in healthy adult subjects.
Stevens RC; Laizure SC; Williams CL; Stein DS
Antimicrob Agents Chemother; 1991 Sep; 35(9):1884-90. PubMed ID: 1952863
[TBL] [Abstract][Full Text] [Related]
2. Multiple-dose pharmacokinetics of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers.
Stevens RC; Laizure SC; Sanders PL; Stein DS
Antimicrob Agents Chemother; 1993 Mar; 37(3):448-52. PubMed ID: 8460913
[TBL] [Abstract][Full Text] [Related]
3. Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy.
Blaser J; Joos B; Opravil M; Lüthy R
Infection; 1993; 21(4):206-9. PubMed ID: 8225622
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of sulphamethoxazole and trimethoprim administered intravenously and orally to Japanese quails.
Lashev LD; Mihailov R
J Vet Pharmacol Ther; 1994 Oct; 17(5):327-30. PubMed ID: 7853455
[TBL] [Abstract][Full Text] [Related]
5. Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim.
Hutabarat RM; Unadkat JD; Sahajwalla C; McNamara S; Ramsey B; Smith AL
Clin Pharmacol Ther; 1991 Apr; 49(4):402-9. PubMed ID: 2015729
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients.
Chin TW; Vandenbroucke A; Fong IW
Antimicrob Agents Chemother; 1995 Jan; 39(1):28-33. PubMed ID: 7695325
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
Siber GR; Gorham CC; Ericson JF; Smith AL
Rev Infect Dis; 1982; 4(2):566-78. PubMed ID: 6981173
[TBL] [Abstract][Full Text] [Related]
8. Ion-paired high-performance liquid chromatographic separation of trimethoprim, sulfamethoxazole and N4-acetylsulfamethoxazole with solid-phase extraction.
Laizure SC; Holden CL; Stevens RC
J Chromatogr; 1990 Jun; 528(1):235-42. PubMed ID: 2384558
[No Abstract] [Full Text] [Related]
9. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
Królicki A
Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
[TBL] [Abstract][Full Text] [Related]
10. Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Stein DS; Stevens RC; Terry D; Laizure SC; Palte S; Lancaster DJ; Weems JJ; Williams CL
Antimicrob Agents Chemother; 1991 Sep; 35(9):1705-9. PubMed ID: 1952835
[TBL] [Abstract][Full Text] [Related]
11. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
[TBL] [Abstract][Full Text] [Related]
12. Intravenous pharmacokinetics and in vitro bactericidal activity of trimethoprim-sulfamethoxazole.
Spicehandler J; Pollock AA; Simberkoff MS; Rahal JJ
Rev Infect Dis; 1982; 4(2):562-5. PubMed ID: 6981172
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.
Mengelers MJ; Van Gogh ER; Kuiper HA; Pijpers A; Verheijden JH; Van Miert AS
J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the conventional methods and high-performance liquid chromatography for the determination of trimethoprim, sulfamethoxazole and its metabolite in serum.
Essers L; Korte H
Chemotherapy; 1982; 28(4):247-52. PubMed ID: 7116979
[TBL] [Abstract][Full Text] [Related]
15. [Studies of the pharmacokinetics and bioavailability of a new trimethoprim/sulfamethoxazole preparation in healthy volunteers].
Hutt V; Klingmann I; Pabst GU; Salama Z; Nieder M; Jaeger H
Arzneimittelforschung; 1988 Sep; 38(9):1347-50. PubMed ID: 3265624
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
Nissenson AR; Wilson C; Holazo A
Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim and sulfamethoxazole transfer in the in vitro perfused human cotyledon.
Bawdon RE; Maberry MC; Fortunato SJ; Gilstrap LC; Kim S
Gynecol Obstet Invest; 1991; 31(4):240-2. PubMed ID: 1885094
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of sulfamethoxazole in healthy Han volunteers living at plain and in native Han and Tibetan healthy volunteers living at high altitude].
Li XY; Liu YN; Li YP; Yuan M; Zhu JB
Yao Xue Xue Bao; 2011 Sep; 46(9):1117-22. PubMed ID: 22121785
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
Brown MP; Gronwall R; Castro L
Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii.
Young LS
Rev Infect Dis; 1982; 4(2):608-13. PubMed ID: 6981177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
